This inventor holds 1 USPTO granted patent. Top assignees: Peking University, The Georgia State University Research Foundation, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 667 
1 out of 205 Years Active: 2021
Title: Innovations of Xiaodan Cai in Hepatitis B Research
Introduction
Xiaodan Cai is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical research, particularly in the development of vaccines for hepatitis B. His innovative work focuses on enhancing immune responses to combat this viral infection.
Latest Patents
Xiaodan Cai holds a patent for a virus-like particle of the hepatitis B virus pre-S protein. This invention utilizes the preS antigen on infectious hepatitis B virus (HBV) particles to provide B and T cell epitopes. These epitopes promote humoral and cellular responses, enhancing the seroprotection rate by overcoming non-responsiveness to S antigen-only vaccines. The disclosed compositions and methods aim to develop vaccines and immune therapies for treating or preventing hepatitis B infection. Specifically, the virus-like particles (VLPs) containing the preS antigen on their surface can be used alone or in combination with vaccines containing the hepatitis B surface antigen (HBsAg) to vaccinate subjects against HBV. Additionally, these VLPs can activate T cells for adoptive T cell therapy to eradicate HBV-infected hepatocytes. Xiaodan Cai has 1 patent to his name.
Career Highlights
Throughout his career, Xiaodan Cai has worked with esteemed institutions, contributing to groundbreaking research in his field. His experience includes positions at the Georgia State University Research Foundation, Inc. and Peking University. These roles have allowed him to collaborate with leading experts and advance his research initiatives.
Collaborations
Xiaodan Cai has collaborated with various professionals in his field, including Ming Luo, who has been a significant coworker in his research endeavors.
Conclusion
Xiaodan Cai's innovative work in hepatitis B research exemplifies the importance of scientific advancements in public health. His contributions through patents and collaborations continue to pave the way for effective treatments and vaccines against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile